PART I General As used in this Annual Report on Form 10-K, references to the Company, Propanc, we, our, and us refer to Propanc Biopharma, Inc. and its consolidated subsidiary, unless otherwise indicated. In addition, references to our financial statements are to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K except as the context otherwise requires. We prepare our consolidated financial statements in United States dollars and in accordance with gener...
Q2 FY2026 — expected 2026-08-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-09-29 | 2025-06-30 | 0001493152-25-016069 | EDGAR | 81K words |
| 2024-09-30 | 2024-06-30 | 0001493152-24-038815 | EDGAR | — |
| 2023-09-28 | 2023-06-30 | 0001493152-23-034632 | EDGAR | — |
| 2022-09-28 | 2022-06-30 | 0001493152-22-027033 | EDGAR | — |
| 2021-09-28 | 2021-06-30 | 0001493152-21-023973 | EDGAR | — |
| 2020-10-01 | 2020-06-30 | 0001493152-20-018726 | EDGAR | — |
| 2019-10-15 | 2019-06-30 | 0001493152-19-015529 | EDGAR | — |
| 2018-09-17 | 2018-06-30 | 0001493152-18-013392 | EDGAR | — |
| 2017-09-28 | 2017-06-30 | 0001493152-17-011027 | EDGAR | — |
| 2016-09-28 | 2016-06-30 | 0001144204-16-125808 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001493152-26-007052 | EDGAR | 41K words |
| 2025-11-14 | 2025-09-30 | 0001493152-25-023213 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010798 | EDGAR | — |
| 2025-02-14 | 2024-12-31 | 0001493152-25-006697 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045664 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019940 | EDGAR | — |
| 2024-02-20 | 2023-12-31 | 0001493152-24-007191 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-040980 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017346 | EDGAR | — |
| 2023-02-10 | 2022-12-31 | 0001493152-23-004150 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-032116 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001493152-22-013577 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-26 | 0001493152-26-008196 | EDGAR | 7K words |
| 2026-01-07 | 0001493152-26-000834 | EDGAR | — |
| 2025-11-10 | 0001493152-25-021567 | EDGAR | — |
| 2025-10-14 | 0001493152-25-018054 | EDGAR | — |
| 2025-08-19 | 0001641172-25-024872 | EDGAR | — |
| 2025-08-13 | 0001641172-25-023580 | EDGAR | — |
| 2025-07-30 | 0001641172-25-021560 | EDGAR | — |
| 2025-07-22 | 0001641172-25-020574 | EDGAR | — |
| 2025-06-27 | 0001641172-25-016719 | EDGAR | — |
| 2025-06-18 | 0001641172-25-015642 | EDGAR | — |
225 total filings indexed. 193 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001517681 |
| Ticker | PPCB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.propanc.com |
| Listed | 2012-06-15 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report